Figure 3 - uploaded by Zvi Vaknin
Content may be subject to copyright.
Photographs of sections through the myometrium showing a cluster of trophoblast cells present in-between smooth muscle bundles (case 8) (haematoxylin and eosin, Q 200). 

Photographs of sections through the myometrium showing a cluster of trophoblast cells present in-between smooth muscle bundles (case 8) (haematoxylin and eosin, Q 200). 

Source publication
Article
Full-text available
Our aim was to supplement the mostly individual case reports on the rarely occurring and life-threatening condition of ectopic pregnancy developing in a Caesarean section scar. Eight of all the patients treated in our department between 1995 and 2002 had been diagnosed for ectopic pregnancy that developed in a Caesarean section scar. They comprised...

Context in source publication

Context 1
... of a pregnancy within a Caesarean ®brous tissue scar is considered to be the rarest form of ectopic pregnancy and a life-threatening condition (Fylstra et al ., 2002). This is because of the very high risk for uterine rupture and all the maternal complications related to it (Herman et al ., 1995; Fylstra, 2002; Jurkovic et al ., 2003). Of the many theories for explaining its occurrence, the most reasonable one seems to be that the blastocyst enters into the myometrium through a microscopic dehiscent tract. This may be created throughout a trauma of a previous Caesarean section, any other uterine surgery (Cheng et al ., 2003), or even following manual removal of the placenta (Fylstra, 2002). Another mechanism for intramural implantation is IVF and embryo transfer, even in the absence of any previous uterine surgery (Hamilton et al ., 1992). The true incidence of pregnancy in scar has not been determined because so few cases have been reported in the literature: there are only 18 published cases in the English medical literature between 1978 and 2001 (Fylstra, 2002). Between 2002 and mid-2003, however, 25 additional cases were reported (Fylstra et al ., 2002; Ghezzi et al ., 2002; 278 Human Reproduction vol. 19 no. 2 ã Haimov-Kochman et al ., 2002; Lam and Lo, 2002; Hartung and Meckies, 2003; Jurkovic et al ., 2003; Salomon et al ., 2003), 18 of which took place in a single centre (Jurkovic et al ., 2003). This may re ̄ect both the increasing number of Caesarean sections being performed and the more widespread use of the transvaginal scan that allows earlier detection of such pregnancies (Jurkovic et al ., 2003). Notwithstanding this recent trend, current knowledge continues to be based mainly upon individual case reports. We present our medical centre's experience of eight ectopic pregnancies implanted in Caesarean scars. The clinical course of our eight patients represents a wide range of symptoms associated with this type of ectopic pregnancy. This is from a silent clinical picture in which the diagnosis was made coincidentally (cases 2±6), through slight vaginal bleeding with no other clinical complaints (cases 1 and 7), or profuse vaginal bleeding with abdominal discomfort (case 8) and ®nally missed abortion (cases 6 and 8). The image modality most frequently used was transvaginal sonography although transabdominal scan was added in two other cases. This combined modality helps to con®rm the implantation site and reduces the risk of false diagnosis. The various treatment modalities which were applied and the outcome of all the eight pregnancies are summarized in Table I. Three cases were treated both by sonographically guided intra-amniotic injection of 25 mg methotrexate (MTX) and i.m. (systemic) administration of (50 mg/m 2 ) on the basis of actual body weight (Stovall et al ., 1991; Stovall and Ling, 1993). Systemic MTX only was administered in case 7. This was because she was an obese woman who had a large ®broid uterus, which obscured the access for the intra-amniotic injection. For each case, where indicated, local MTX was injected only once. All procedures were conducted on an outpatient basis. The injection was performed transvaginally, under continuous ultrasound guidance and by using a 20-G needle. Neither antibiotic prophylaxis nor analgesia were administrated. The gestational sac was targeted and the amniotic ̄uid was aspirated. This was immediately followed by the local MTX injected. Our adopted protocol for the systemic MTX administration and the patient monitoring was reported elsewhere (Stovall et al ., 1991; Stovall and Ling, 1993). Transcervical complete aspiration of the gestational sac under ultrasound guidance was performed without any complementary medical treatment in case 2, although the exact aspiration of a very small gestational sac may also facilitate pregnancy absorption (Ravhon et al ., 1997; Jurkovic et al ., 2003). However, this unusual treatment approach should be addressed with great caution in the future. Since in case 6 the diagnosis was missed abortion, expectant management was chosen in this situation. Open surgery was needed only in two cases and both of them underwent an emergency laparotomy because of profuse haemorrhage. In one case (case 1) (Herman et al ., 1995), uterine rupture occurred at 35 weeks gestation. After delivery of a healthy infant, Caesarean hysterectomy was needed. In the second case (case 8; Figure 2), severe vaginal bleeding started during vacuum aspiration of an 8 weeks gestation missed abortion. Since in the specimens no products of conception were found, another ultrasound was conducted and only then was the correct diagnosis made (Figure 2b). Because of the combin- ation of pregnancy in scar and heavy vaginal bleeding, emergency laparotomy (Figure 2C) and excision of the pregnancy located in the scar was carried out. Following surgery, portions of uterine wall consisting of endometrium and myometrium were retrieved. The ®nal histology examination revealed clusters of trophoblast cells as well as scattered syncytiotrophoblast cells invading the myometrium. Decidual stromal changes were also noted and they were accompanied by foci of haemorrhage and disintegration of tissues (Figure 3). Immunostaining with b -hCG and desmin con®rmed the presence of trophoblast cells within smooth muscle myometrial ®bres. Follow-up ranged between 4 and 16 weeks (with the exception of case 1). This was based on weekly serum b -hCG measurements. The women were tested for serum b -hCG levels within the community medical care system. In addition, sonographic examination was performed weekly in our outpatient clinic until pregnancy remnants could not be further detected. In all cases, following the original treatment, maternal recovery was complete and there was no need for additional interventions. No side-effects related to MTX treatment were recorded. The women who were planning future pregnancies were advised to have an early vaginal scan to con®rm the intrauterine location of the new gestation. Two pregnant women (cases 4 and 6) have spontaneously conceived an in utero pregnancy. In one case (case 6), Caesarean section at term was performed because of fetal distress. No signs of previous pregnancy in scar were seen in the repeated operation. In the other case (case 4), the woman had two miscarriages following this event. Although a recent report was published by Jurkovic et al . (2003) describing the outcome of 18 cases of pregnancies implanted in scarred uterus, we believe that additional case series are needed for further elucidate this issue. Vial et al . (2000) proposed that there were two different types of such ectopic pregnancies, both of which were encountered among our patients. The ®rst is due to the implantation of the gestational sac on the scar with progression towards either the cervico-isthmic space or towards the uterine cavity. Such a ...

Similar publications

Article
Full-text available
We report two cases of Caesarean scar pregnancies that were managed surgically. The first case was a 33-year-old woman who presented at 21 weeks of gestation with lower abdominal pain. An exploratory laparotomy was performed as she was hypotensive and had a drastic drop in haemoglobin level. Intraoperatively, a ruptured scar ectopic pregnancy with...

Citations

... Asymptomatic cases can also occur in this condition. Studies conducted by Maymon et al. 6 and Lorena et al. 5 reported that 36.5 and 30.4% of cases, respectively, were asymptomatic. Similarly, in our study, we observed an asymptomatic presentation in 30.4% of patients. ...
... [14][15][16][17][18] Compared to medical treatment, laparotomy resulted in a shorter follow-up period and a lower risk of rupture of the uterus or recurrence at the site of repair. 6,14 Based on these findings, excision of the scar pregnancy by laparotomy may be considered a viable treatment option for scar pregnancy. As with any surgical procedure, there are potential risks and complications that should be weighed against the potential benefits. ...
... In addition, expectant CSP treatment is prone to severe maternal complications such as massive hemorrhage, placenta accreta spectrum, and uterine rupture. Given these significant risks, pregnancy termination after CSP diagnosis is recommended [8][9][10]. Several surgical and drug treatments are available for this condition [11][12][13][14], but there is no optimal treatment to date. ...
Article
Full-text available
Background Cesarean scar pregnancy (CSP) is a long-term complication of cesarean section characterized by the localization of a subsequent gestational sac within the scar area or niche developed as a result of a previous cesarean section. Its incidence has increased substantially because of the high global cesarean section rate in recent decades. Several surgical and drug treatments exist for this condition; however, there is currently no optimal treatment. This study compared the effectiveness of direct hysteroscopic removal of the gestational tissue and hysteroscopy combined with vacuum suction for the treatment of CSP. Methods From 2017 to 2023, 521 patients were diagnosed with CSP at our hospital. Of these patients, 45 underwent hysteroscopy. Among them, 28 underwent direct hysteroscopic removal (hysteroscopic removal group) and 17 underwent hysteroscopy combined with vacuum suction (hysteroscopic suction group). The clinical characteristics and outcomes of the hysteroscopic removal group and hysteroscopic suction group were analyzed. Results Among the 45 patients, the amount of bleeding and hospitalization cost were significantly higher in the hysteroscopic removal group than in the hysteroscopic suction group (33.8 mL vs. 9.9 mL, P < 0.001; and 8744.0 yuan vs. 5473.8 yuan, P < 0.001; respectively). The operation time and duration of hospitalization were significantly longer in the hysteroscopic removal group than in the hysteroscopic suction group (61.4 min vs. 28.2 min, P < 0.001; and 3.8 days vs. 2.4 days, P = 0.026; respectively). Three patients in the hysteroscopic removal group had uterine perforation and received laparoscopic repair during operation. No complications occurred in the hysteroscopic suction group. One patient in the hysteroscopic removal group received ultrasound-guided suction curettage due to postoperative moderate vaginal bleeding, and one patient in the hysteroscopic suction group received ultrasound-guided suction curettage due to postoperative gestational residue and elevated serum beta-human chorionic gonadotropin levels. Reproductive function was preserved in all patients. Conclusions Hysteroscopy is an effective method for treating CSP. Compared with direct hysteroscopic removal, hysteroscopy combined with vacuum suction is more suitable for CSP. However, multicenter prospective studies with large sample sizes are required for verification of these findings.
... Maymon et al 16 published a systematic review and meta-analysis of 22 studies involving 374 patients with CSP. The review reported a success rate of 92.2% for suction evacuation treatment and a low complication rate, 16 similar to the findings of this study. A previously published systematic review by Ilan Timor-Tritsch 2 based on smaller case series reported a complication rate for dilatation and curettage of 62.9%; this higher complication rate was attributed principally to bleeding complications. ...
Article
Background A cesarean scar pregnancy is an iatrogenic consequence of a previous cesarean delivery. The gestational sac implants into a niche created by the incision of the previous cesarean delivery, and this carries a substantial risk for major maternal complications. The aim of this study was to report, analyze, and compare the effectiveness and safety of different treatments options for cesarean scar pregnancies managed in the first trimester through a registry. Objective This study aimed to evaluated the ultrasound findings, disease behavior, and management of first-trimester cesarean scar pregnancies. Study Design We created an international registry of cesarean scar pregnancy cases to study the ultrasound findings, disease behavior, and management of cesarean scar pregnancies. The Cesarean Scar Pregnancy Registry collects anonymized ultrasound and clinical data of individual patients with a cesarean scar pregnancy on a secure, digital information platform. Cases were uploaded by 31 participating centers across 19 countries. In this study, we only included live and failing cesarean scar pregnancies (with or without a positive fetal heart beat) that received active treatment (medical or surgical) before 12+6 weeks’ gestation to evaluate the effectiveness and safety of the different management options. Patients managed expectantly were not included in this study and will be reported separately. Treatment was classified as successful if it led to a complete resolution of the pregnancy without the need for any additional medical interventions. Results Between August 29, 2018, and February 28, 2023, we recorded 460 patients with cesarean scar pregnancies (281 live, 179 failing cesarean scar pregnancy) who fulfilled the inclusion criteria and were registered. A total of 270 of 460 (58.7%) patients were managed surgically, 123 of 460 (26.7%) patients underwent medical management, 46 of 460 (10%) patients underwent balloon management, and 21 of 460 (4.6%) patients received other, less frequently used treatment options. Suction evacuation was very effective with a success rate of 202 of 221 (91.5%; 95% confidence interval, 87.8–95.2), whereas systemic methotrexate was least effective with only 38 of 64 (59.4%; 95% confidence interval, 48.4–70.4) patients not requiring additional treatment. Overall, surgical treatment of cesarean scar pregnancies was successful in 236 of 258 (91.5%, 95% confidence interval, 88.4–94.5) patients and complications were observed in 24 of 258 patients (9.3%; 95% confidence interval, 6.6–11.9). Conclusion A cesarean scar pregnancy can be managed effectively in the first trimester of pregnancy in more than 90% of cases with either suction evacuation, balloon treatment, or surgical excision. The effectiveness of all treatment options decreases with advancing gestational age, and cesarean scar pregnancies should be treated as early as possible after confirmation of the diagnosis. Local medical treatment with potassium chloride or methotrexate is less efficient and has higher rates of complications than the other treatment options. Systemic methotrexate has a substantial risk of failing and a higher complication rate and should not be recommended as first-line treatment.
... Higher incidence (41.2%) of PID is also found in Seo et al. study. [12] However, PID as a risk factor for ectopic pregnancies has been found in 15%-20% patients and induced abortions in 36% in a study by Tahmina S. [13] The recurrence of ectopic pregnancy in our study was (2/32) 6.2%, and in literature, it ranges from 2% to 10%. Amenorrhea is not present in 100% of cases of ectopic pregnancies. ...
... Since this condition affects women of reproductive age, the treatment of choice should be tailored to preserve fertility. Expectant management is not usually recommended due to the risk of severe complications [7,19,20]. Methotrexate is the most widely used treatment modality. Ko et al. [21] reported an 80 % success rate with the use of intralesional methotrexate with or without potassium chloride in their series. ...
Article
Full-text available
Objective The purpose of the study was to assess the efficacy of local ultrasound-guided methotrexate injection in patients with caesarean section scar pregnancy, to chart the course of beta-human chorionic gonadotropin levels (HCG) after treatment, and to see if HCG levels are correlated with clinical presentation. Methods Between May 2018 and January 2021, data were collected retrospectively from the Early Pregnancy Unit of a tertiary hospital. Results Our clinic assessed 20 patients; one disputed terminating the pregnancy and was not included in the research. The remaining 19 patients, with a median age of 34 years, received intragestational sac methotrexate injection under ultrasound guidance. 7w3d was the median gestational age. These women had one to four previous caesarean sections, with a mean of 1.60±9. Patients with caesarean scar pregnancy most typically presented with spotting (42.1%), whereas 26.3% were asymptomatic. Except in cases of pain, the symptomatic women’s HCG levels were lower than in the non-symptomatic women. The level of HCG in patients with pain was approximately double that of non-pain patients (p=0.2557). In our series, intragestational sac methotrexate injection was effective in 17/19 women, or 89.5% (95%CI: 75.7-100%). HCG levels were undetectable in 97.6±30 days on average (minimum: 42 days, maximum: 147 days). Conclusion Caesarean scar pregnancy is a rare possibly fatal condition with no consensus on the optimal treatment. An experienced Early Pregnancy Unit member performing local methotrexate injections under ultrasound guidance is a feasible and successful strategy in clinically stable patients.
... Several possible mechanisms are thought to influence the implantation of the gestational sac on the scar. One is the invasion of the myometrium through a microtubular dehiscent tract between the cesarean scar (CS) and the endometrial canal [5,20,[22][23][24]. Myometrial scar tissue frequently presents with myofiber disarray, inflammation, elastosis, tissue edema, apoptosis, and decreased smooth muscle volume density [14,25], allowing extravillous trophoblastic cells to invade beyond the inner third of the myometrium and reach the outer myometrial vessels [25]. ...
Article
Full-text available
A Cesarean Scar Pregnancy (CSP) is a variant of uterine ectopic pregnancy defined by full or partial implantation of the gestational sac in the scar of a previous cesarean section. The continuous increase of Cesarean Deliveries is causing a parallel increase in CSP and its complications. Considering its high morbidity, the most usual recommendation has been termination of pregnancy in the first trimester; however, several cases progress to viable births. The aim of this systematic review is to evaluate the outcome of CSP managed expectantly and understand whether sonographic signs could correlate to the outcomes. An online-based search of PubMed and Cochrane Library Databases was used to gather studies including women diagnosed with a CSP who were managed expectantly. The description of all cases was analysed by the authors in order to obtain information for each outcome. 47 studies of different types were retrieved, and the gestational outcome was available in 194 patients. Out of these, 39 patients (20,1%) had a miscarriage and 16 (8,3%) suffered foetal death. 50 patients (25,8%) had a term delivery and 81 (41,8%) patients had a preterm birth, out of which 27 (13,9%) delivered before 34 weeks of gestation. In 102 (52,6%) patients, a hysterectomy was performed. Placenta Accreta Spectrum (PAS) was a common disorder among CSP and was linked to a higher rate of complications such as foetal death, preterm birth, hysterectomy, haemorrhagic morbidity and surgical complications. Some of the analysed articles showed that sonographic signs with specific characteristics, such as type II and III CSP classification, Crossover Sign – 1, “In the niche” implantation and lower myometrial thickness could be related to worse outcomes of CSP. This article provides a good understanding of CSP as an entity that, although rare, presents with a high rate of relevant morbidity. It is also understood that pregnancies with confirmed PAS had an even higher rate of morbidity. Some sonographic signs were shown to predict the prognosis of these pregnancies and further investigation is necessary to validate one or more signs so they can be used for a more reliable counselling of women with CSP.
... J o u r n a l P r e -p r o o f been confirmed in several other studies [32][33][34][35] and it has been suggested that rather than the number of CBs, the indication for CB may have a more significant impact on the risk of CSEP development, in particular elective CB for breech presentation could increase the risk of CSEP in subsequent pregnancies [31,32,36]. Breech CBs usually are performed as elective pre labour procedures with uterine incisions being made higher up in the anterior uterine wall compared to emergency CB. ...
... J o u r n a l P r e -p r o o f been confirmed in several other studies [32][33][34][35] and it has been suggested that rather than the number of CBs, the indication for CB may have a more significant impact on the risk of CSEP development, in particular elective CB for breech presentation could increase the risk of CSEP in subsequent pregnancies [31,32,36]. Breech CBs usually are performed as elective pre labour procedures with uterine incisions being made higher up in the anterior uterine wall compared to emergency CB. ...
... Although TVS examination is considered the primary diagnostic tool for CSEP, as it provides the highest resolution images, several groups propose it should be used in combination with transabdominal imaging to reduce the risk of false positive diagnoses [32]. Transabdominal scan with a full bladder provides a panoramic view of the uterus allowing accurate assessment of the measurement between the gestational sac and the bladder [32,54] but may be impossible in patients with a high body mass index (BMI). ...
Article
Cesarean scar ectopic pregnancy is a rare type of ectopic pregnancy, where the pregnancy implants into a myometrial defect caused by a cesarean scar. Its incidence is predicted to increase, given the global increase in cesarean deliveries. As most cesarean scar ectopic pregnancies present as failing pregnancies or patients choose termination of pregnancy, there are limited data on their natural history. However, early first trimester diagnosis is essential, given the associated significant maternal morbidity. Transvaginal sonography is generally considered to be the optimal method for diagnosing cesarean scar ectopic pregnancy. There is no evidence that MRI adds to the diagnostic accuracy, and it is therefore not recommended for routine evaluation of cesarean scar ectopic pregnancy. There is no agreed reference standard for the diagnosis of cesarean scar ectopic pregnancy; therefore, the validity of several proposed sonographic diagnostic criteria reported by different authors remains unknown. There are also various suggested classification systems for cesarean scar ectopic pregnancy, which divide them in differet types. However, the proposals are very heterogeneous, and superiority of one classification system over another is yet to be established.
... CSP is currently defined as an embryo whose basalis implants in the scar tissue from a previous cesarean hysterotomy. This condition is reported to be associated with a high rate of severe maternal morbidity and mortality (1)(2)(3)(4)(5). Although rare, the incidence of CSP has been steadily increasing along with the rate of cesarean deliveries, reaching an estimated incidence between ...
... However, it is unclear whether the number of previous cesarean deliveries further increases the risk, and current literature indicates that 52% occur in patients with only one prior cesarean (1). The cesarean scar pregnancy is a relatively new term to describe those low implantations of the basalis in the first trimester that are near the cesarean scar and have ultrasound characteristics that are associated with increased morbidity due to placental accreta spectrum (PAS) (1)(2)(3)(4)(5)(6)(7)(8)(9)(10)(11)(12)(13)(14)(15)(16)(17). The Society for Maternal Fetal Medicine (SMFM) issued guidelines focusing on the ultrasound (US) parameters of presence of the niche or ovoid appearance near the scar, smallest myometrial thickness, and evidence of increased vascularity of the basalis in the lower uterine segment near the scar (1). ...
... The Society for Maternal Fetal Medicine (SMFM) issued guidelines focusing on the ultrasound (US) parameters of presence of the niche or ovoid appearance near the scar, smallest myometrial thickness, and evidence of increased vascularity of the basalis in the lower uterine segment near the scar (1). Symptoms of CSP in the first trimester are variable, the most common of which is vaginal bleeding (1)(2)(3)(4)(5)(6)(7)(8)(9)(10)(11)(12)(13)(14)(15)(16)(17). ...
Article
Full-text available
Background: The nomenclature has evolved from low implantation to cesarean scar pregnancy and criteria are recommended for identification. Management guidelines include pregnancy termination due to life-threatening complications. Objective: To apply ultrasound (US) parameters recommended by the Society for Maternal Fetal Medicine to terminate CSP pregnancies in women with who were expectantly managed. Study design: Pregnancies were identified between 3/1/2013 and 12/31/2020. Inclusion criteria were women with CSP or low implantation identified on US. Studies were reviewed for niche, smallest myometrial thickness (SMT), and location of basalis blinded to clinical data. Clinical outcomes: pregnancy outcome, need for intervention, hysterectomy, transfusion, pathologic findings, and morbidities, were obtained by chart review. Results: Of 101 pregnancies with low implantation, 43 met Society for Maternal Fetal Medicine (SMFM) criteria <10 weeks and 28 at 10-14 weeks for CSP. At < 10 weeks, SMFM criteria identified 45/76 women; of these 13 required hysterectomy; there were 6 who required hysterectomy who did not meet SMFM criteria. At 10-<14 weeks, SMFM criteria identified 28/42 women; of these 15 required hysterectomy. US parameters yielded significant differences in women requiring hysterectomy, at<10 weeks and 10<14weeks gestational age epochs, but the sensitivity, specificity, positive and negative predictive values of these US parameters have limitations in identifying invasion to determine management. Of the 101 pregnancies, 46 (46%) failed < 20 weeks, 16 (35%) required medical/surgical management including 6 hysterectomies; 30 (65%) required no intervention. There were 55 pregnancies (55%) that progressed beyond 20 weeks. Of these, 16 required hysterectomy (29%) while 39 (71%) did not. In the overall cohort of 101, 22 (21.8%) required hysterectomy and an additional16 (15.8%) required some type of intervention, while 66.7% required no intervention. Conclusion: SMFM US criteria were positive in yielding significant findings, but the sensitivity, specificity, PPV and NPV have limitations in discerning clinical management.
... With nearly 100 cases described in the literature since 1978, this initially exceptional ectopic pregnancy is increasing in frequency [3]. The incriminated risk factors are similar to those of placenta accreta: on the one hand, the number of previous cesarean sections and endouterine gestures (curettages, manual uterine revision), on the other hand, IVF techniques with embryo transfer are also discussed in the mechanism [1,4,5]. ...
... This would allow a better appreciation of the volume of the lesion and guide the therapeutic choices [6,12]. If the diagnosis is obvious on two-dimensional ultrasound, these advanced examinations are not recommended [4]. ...
Article
Full-text available
Background: Among the different forms of ectopic pregnancy, cesarean scar pregnancy is one of the most uncommon with an estimated incidence of 1/1800 pregnancies. A major risk of massive hemorrhage, it requires active management as soon as it is diagnosed because it can affect the functional prognosis of the patient (hysterectomy) but can also be life-threatening. Different surgical techniques are generally proposed in first intention to patients who no longer wish to have children, who are hemodynamically unstable and/or in case of failure of medical treatment. Case presentation: We hereby report the case of a young 19-year-old patient with no particular medical history, gravida 2 para 1 with a live child born after a cesarean section for fetal heart rhythm abnormalities during labor 5 months earlier and who presented to the emergency room of our structure for the management of a cesarean pregnancy scar diagnosed at 6 weeks of amenorrhea. She was successfully managed with an intramuscular injection of methotrexate. The follow-up was uneventful. Conclusion: The implantation of a pregnancy on a cesarean section scar is becoming more and more frequent. With consequences that can be dramatic, ranging from hysterectomy to life-threatening hemorrhage, clinicians must be familiar with this pathological entity and be prepared for its management. The latter must be rapid and allow, if necessary, the preservation of the patient's fertility. In this sense, conservative medical treatment with methotrexate injections should be proposed as a first-line treatment in the absence of contraindication.
... Although a variety of treatments have been described, there is no consensus on the optimal management approach [5][6][7][8][9][10]. Many grading systems for CSP have been proposed [11][12][13][14]. ...
Article
Full-text available
Background Cesarean scar pregnancy (CSP) is a long-term complication after cesarean section that can cause severe maternal morbidity and mortality. Although a variety of treatments have been described, there is no consensus as to the optimal management approach. Many grading systems for CSP have been proposed, among which the classification made by the consensus of Chinese experts in 2016 was shown to provide improved treatment guidance for clinical practice. The purpose of the present study was to analyze the success rate of different treatments for each type of CSP as classified according to the Chinese Expert’s Consensus (2016), and to develop a management strategy for CSP. Methods A retrospective study was performed among patients diagnosed with CSP at Shandong Provincial Hospital between January 2009 and December 2019. We reviewed clinical characteristics, treatment methods, and subsequent outcomes; and analyzed these endpoints using the statistical software package SPSS 22.0 (SPSS, Inc., Chicago, IL). Results For type I CSP, systemic methotrexate (MTX) administration exhibited a success rate of 79.2% for type Ia and 14.3% for type Ib. Local and systemic MTX administration success rates were 88.9% for type Ia and 66.7% for type Ib. Dilation and curettage (D&C), curettage after uterine artery embolization (UAE + C), and hysteroscopic curettage (H + C) were 100% successful. For type II, UAE + C, H + C, and laparoscopy combined with hysteroscopic curettage (L + H+C) were 100% successful. D&C had a success rate of 97.0% for type IIa and 88.9% for type IIb. The success rate of systemic MTX administration was 52.0% for type IIa and 62.5% for type IIb. Both UAE + C and L + H+C had 100% success rates for type IIIa CSPs, while for type IIIb, the success rate was 87.9% for UAE + C vs. 96.6% for L + H+C. Conclusions For type I CSPs, D&C was quick, easy, and safe; for type II, H + C was more suitable. For type III and some type II patients who wished to undergo simultaneous repair of the cesarean defect, L + H+C was the optimal method. UAE can be used as a complementary option instead of a prophylactic measure, and when difficulties with endoscopic surgeries were encountered, conversion to laparotomy was the ultimate treatment.